Financial Daily from THE HINDU group of publications
Wednesday, Apr 27, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate - Research & Development


NCL, DuPont sign research pact

Our Bureau

Pune , April 26

DUPONT has announced that it has signed a research agreement with the Pune-based National Chemical Laboratory (NCL).

Under the terms of the agreement, DuPont will have access to the talent and capabilities of NCL to grow new market-facing technologies.

NCL's first research project will be for DuPont Titanium Technologies, according to an official communication here on Monday.

The research agreement was signed by Dr S. Sivaram, Director, NCL, and Dr Thomas M. Connelly Jr, Senior Vice-President and Chief Science and Technology Officer, DuPont, at Wilmington, Delaware, US, on April 22.

"We are pleased to announce the signing of this agreement with National Chemical Laboratory of India," said Mr Connelly Jr.

"This move is consistent with DuPont's efforts to go where growth is and to globalise our R&D operations. It furthers DuPont efforts to open our innovation processes by incorporating the research capabilities and intellectual talent of India's top materials scientists. In addition, it will allow us to more clearly address the market needs of the region by providing geographic access."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
NCL, DuPont sign research pact


Ocimum launches its brand of biochips
BILT forays into tissue paper, eyes acquisitions
Vehicle financing to contribute 12 pc of Tata Motors' PBT
Tata Steel may open retail outlets
Zutshi is now Deputy MD of Samsung India
Audi launches A6, priced at Rs 42.5 lakh
Rane Engine Valves EOU
Adlabs board okays pref issue to Arisaig Partners
Plea for probe into Birla Corpn shareholding pattern dismissed
Anil Ambani writes to SEBI
`IPCL stock sale: Reliance Capital loss Rs 1,000 cr'
`Laws governing corporate sector must be remodelled'
Eco violations: Reliance Energy fine cut to Rs 100 cr
Sterlite Optical Q4 net up at Rs 2.9 cr
Parliamentary panel seeks revamp of SAIL corporate plan
Ruia group all set to acquire sick Orissa PSU
Blue Star on major expansion drive
Bal Pharma eyeing North Indian location
Daewoo assets sell-off may be mired in more legal tangles
Glenmark's Swiss arm in deal with Teijin Pharma of Japan
Development, expansion of Tapti gas field: British Gas-ONGC-Reliance joint venture plans to invest $500 m
ONGC security reviewed
STC plans foray into new areas
The great growth story
Starting up a brand new day
Torrent launches anti-epileptic drug
Panacea launches pain relief drug


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line